Clin2
NCT07693244Possibly a fitRecruiting

Exosome therapy for male pattern baldness

Androgenetic Alopecia (AGA)

Part of Skin clinical trials.

This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Men ages 18 to 55 with male pattern baldness (Norwood-Hamilton grade III-V).
  • Hair loss has been stable (not getting worse) for at least 6 months.
  • You agree not to use any other hair loss treatments during the study and for 6 months after.
  • You have not used hair loss medications like minoxidil or finasteride in the past year.
  • You have not had scalp procedures (like PRP or laser cap) in the past 6 months.
  • You do not have other types of hair loss, active scalp infections, autoimmune disease, or certain health conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06622824Not yet recruiting· Phase 2/Phase 3
Study of a new scalp solution for male hair loss

This study tests a new scalp solution (KX-826) for men with androgenetic alopecia, commonly known as male pattern baldness. It aims to see if the solution can help regrow hair and is safe to use. Participants will apply the solution to their scalp and have their hair growth monitored over time.

Beijing
NCT06764329Enrolling by invitation· Phase 1/Phase 2
Stem cell therapy for male hair loss

This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.

Rawalpindi
NCT07327359Recruiting· Phase 1/Phase 2
Hair loss treatment for men with male pattern baldness

This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.

Botany, New South Wales
NCT07603544Recruiting
Hair Loss Study: Understanding Male Pattern Baldness

This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.

Xinxiang, Henan
NCT07529977Not yet recruiting· Phase 3
Oral minoxidil pill for male hair loss

This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.

NCT07758400Not yet recruiting
Microneedling for male pattern hair loss

This study tests whether microneedling (a procedure using tiny needles on the scalp) can safely help regrow hair in men with male pattern baldness. Participants will receive the procedure and be monitored over time with scalp photos.

Beijing, Beijing Municipality

Hear when a new Androgenetic Alopecia (AGA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.